Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) Accumulated Expenses (2016 - 2026)

Orthofix Medical has reported Accumulated Expenses over the past 17 years, most recently at $23.3 million for Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses changed N/A year-over-year to $23.3 million, compared with a TTM value of $23.3 million through Mar 2026, changed N/A, and an annual FY2025 reading of $27.0 million, up 137.26% over the prior year.
  • Accumulated Expenses came in at $23.3 million for Q1 2026, down from $27.0 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $27.0 million in Q4 2025 to a low of $7.0 million in Q4 2023.
  • Median Accumulated Expenses over the past 5 years was $18.5 million (2022), compared with a mean of $17.4 million.
  • The sharpest move saw Accumulated Expenses tumbled 62.23% in 2023, then surged 137.26% in 2025.
  • Over 5 years, Accumulated Expenses stood at $18.5 million in 2022, then tumbled by 62.23% to $7.0 million in 2023, then surged by 62.73% to $11.4 million in 2024, then surged by 137.26% to $27.0 million in 2025, then decreased by 13.79% to $23.3 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Accumulated Expenses are $23.3 million (Q1 2026), $27.0 million (Q4 2025), and $11.4 million (Q4 2024).